Stockscreener 앱 받기
16.25
4.25%
0.71
전일 마감가:
$15.54
열려 있는:
$15.54
하루 거래량:
217.33K
Relative Volume:
1.61
시가총액:
$197.55M
수익:
$1.54M
순이익/손실:
$-38.70M
주가수익비율:
-3.4797
EPS:
-4.67
순현금흐름:
$-36.86M
1주 성능:
+11.57%
1개월 성능:
+70.53%
6개월 성능:
+168.21%
1년 성능:
-13.74%
1일 변동 폭
$15.00
$16.33
1주일 범위
$13.40
$16.97
52주 변동 폭
$4.64
$20.77
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
명칭
Corbus Pharmaceuticals Holdings Inc
전화
617-963-0103
주소
500 RIVER RIDGE DRIVE, NORWOOD, MA
CRBP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
16.12 | 190.45M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.62 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.68 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.20 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 재개 | B. Riley Securities | Buy |
| 2025-02-28 | 개시 | William Blair | Outperform |
| 2024-12-02 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 개시 | Wedbush | Outperform |
| 2024-07-22 | 재개 | H.C. Wainwright | Buy |
| 2024-06-26 | 개시 | B. Riley Securities | Buy |
| 2024-06-03 | 재확인 | Oppenheimer | Outperform |
| 2024-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2024-03-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-09-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-09-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-09-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-08 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2020-07-07 | 개시 | ROTH Capital | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-03-26 | 개시 | Nomura | Buy |
| 2019-04-05 | 개시 | Jefferies | Buy |
| 2019-03-20 | 개시 | Oppenheimer | Outperform |
| 2019-01-11 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-12-26 | 개시 | H.C. Wainwright | Buy |
| 2018-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2018-10-24 | 개시 | B. Riley FBR | Buy |
| 2018-01-19 | 개시 | Raymond James | Outperform |
| 2017-12-14 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-11-08 | 재확인 | Noble Financial | Buy |
| 2017-09-29 | 재개 | Noble Financial | Buy |
| 2017-03-30 | 재확인 | Cantor Fitzgerald | Overweight |
| 2016-11-15 | 재확인 | JMP Securities | Mkt Outperform |
| 2016-11-11 | 재확인 | Noble Financial | Buy |
모두보기
Corbus Pharmaceuticals Holdings Inc 주식(CRBP)의 최신 뉴스
Can swing trading help recover from Corbus Pharmaceuticals Holdings Inc. lossesMarket Trend Report & Reliable Entry Point Alerts - newser.com
How to build a dashboard for Corbus Pharmaceuticals Holdings Inc. stockDay Trade & Weekly Market Pulse Updates - newser.com
How sentiment analysis helps forecast Corbus Pharmaceuticals Holdings Inc.Earnings Recap Summary & Growth-Oriented Investment Plans - newser.com
Visual analytics tools that track Corbus Pharmaceuticals Holdings Inc. performanceJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - newser.com
Why Corbus Pharmaceuticals Holdings Inc. stock is favored by pension fundsQuarterly Portfolio Summary & Weekly High Potential Alerts - newser.com
What analysts say about Corbus Pharmaceuticals Holdings Inc 3371 stockBull Market Opportunities & Free Real-Time Trading Signals - earlytimes.in
Can Corbus Pharmaceuticals Holdings Inc. (3371) stock deliver strong annual returnsMarket Performance Report & Verified Short-Term Plans - newser.com
Is Corbus Pharmaceuticals Holdings Inc. reversing from oversold territoryTake Profit & Long-Term Capital Growth Strategies - newser.com
Can Corbus Pharmaceuticals Holdings Inc. hit a new high this monthAnalyst Upgrade & Proven Capital Preservation Methods - newser.com
Is a relief rally coming for Corbus Pharmaceuticals Holdings Inc. holdersQuarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Is Corbus Pharmaceuticals Holdings Inc. stock reversal real or fakeJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com
Corbus Pharmaceuticals' (CRBP) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
How Corbus Pharmaceuticals Holdings Inc. (3371) stock valuation compares with sector2025 Earnings Surprises & Daily Entry Point Trade Alerts - newser.com
After-Hours Surge: Turn Therapeutics Rockets 134% Post-Close On Nasdaq Debut; Biotech Stocks Rally - RTTNews
Corbus Pharmaceuticals to Participate in the Upcoming Piper Sandler Virtual Oncology Symposium - GlobeNewswire
Oct 9 Fireside Chat 10:00AM ET — Corbus CEO Yuval Cohen to Present at Piper Sandler Virtual Oncology Symposium - Stock Titan
What analysts say about Corbus Pharmaceuticals Holdings Inc stockMarket Capitalization Trends & Affordable Trading Growth - earlytimes.in
Corbus Pharmaceuticals Holdings Inc. stock outlook for YEARAnalyst Upgrade & Safe Entry Zone Tips - newser.com
Best data tools to analyze Corbus Pharmaceuticals Holdings Inc. stockQuarterly Risk Review & Daily Oversold Bounce Ideas - newser.com
Published on: 2025-10-05 06:30:04 - newser.com
Is Corbus Pharmaceuticals Holdings Inc. stock gaining market share2025 Risk Factors & Free Long-Term Investment Growth Plans - newser.com
Published on: 2025-10-05 03:14:17 - newser.com
Published on: 2025-10-05 02:56:16 - newser.com
Can Corbus Pharmaceuticals Holdings Inc. stock maintain operating margins2025 AllTime Highs & Low Drawdown Investment Strategies - newser.com
Institutional scanner results for Corbus Pharmaceuticals Holdings Inc.Portfolio Value Summary & Growth Focused Stock Pick Reports - newser.com
These Are The 3 Top-Rated Cannabis Stocks To Buy As Trump Backs CBD - Barchart.com
Oppenheimer lowers Corbus Pharmaceuticals stock price target ahead of ESMO data - Investing.com Canada
What drives Corbus Pharmaceuticals Holdings Inc 3371 stock priceTrade Execution Strategies & Exceptional Growth Investment - earlytimes.in
Corbus Pharmaceuticals (NASDAQ:CRBP) Shares Cross Above 50-Day Moving AverageTime to Sell? - MarketBeat
Published on: 2025-09-29 15:28:09 - newser.com
Published on: 2025-09-29 13:16:49 - newser.com
Published on: 2025-09-29 09:08:59 - newser.com
Published on: 2025-09-29 06:04:12 - newser.com
Leading vs lagging indicators on Corbus Pharmaceuticals Holdings Inc. performance2025 Price Action Summary & AI Driven Price Forecasts - newser.com
Corbus Pharmaceuticals Holdings Inc (CRBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Corbus Pharmaceuticals Holdings Inc 주식 (CRBP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Altmeyer Anne | Director |
May 30 '25 |
Sale |
7.25 |
1,392 |
10,096 |
1,391 |
| Smethurst Dominic | Chief Medical Officer |
Mar 06 '25 |
Sale |
6.78 |
6,393 |
43,330 |
70,807 |
1.10%
자본화:
|
볼륨(24시간):